| review article | Q7318358 |
| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P356 | DOI | 10.1002/14651858.CD004865.PUB2 |
| P698 | PubMed publication ID | 16856063 |
| P2093 | author name string | Arne Ohlsson | |
| Sanjay M Aher | |||
| P2860 | cites work | Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants | Q24245418 |
| The use of erythropoietin in neonates | Q34032616 | ||
| The biology of erythropoietin in the central nervous system and its neurotrophic and neuroprotective potential | Q34199255 | ||
| Effect of recombinant erythropoietin on "late" transfusions in the neonatal intensive care unit: a meta-analysis | Q34565026 | ||
| Iron status and the treatment of the anemia of prematurity | Q34777475 | ||
| Erythropoietin in the central nervous system, and its use to prevent hypoxic-ischemic brain damage | Q35023300 | ||
| Studies on the liver to kidney switch of erythropoietin production | Q36997935 | ||
| Anemia of prematurity. Current concepts in the issue of when to transfuse. | Q39728647 | ||
| Current issues in neonatal transfusions | Q39740201 | ||
| Changing patterns of red blood cell transfusion in very low birth weight infants. | Q40922497 | ||
| Long-acting erythropoietin: clinical studies and potential uses in neonates | Q44926457 | ||
| Erythropoietin treatment in extremely low birth weight infants: blood in versus blood out. | Q47182794 | ||
| Effect of beginning recombinant erythropoietin treatment within the first week of life, among very-low-birth-weight neonates, on "early" and "late" erythrocyte transfusions: a meta-analysis | Q47262085 | ||
| Anemia of prematurity | Q67297967 | ||
| Postnatal changes in erythropoietin levels in untransfused premature infants | Q72712592 | ||
| Blood transfusion. Iron load and retinopathy of prematurity | Q73478410 | ||
| Meta-analysis of controlled clinical trials studying the efficacy of rHuEPO in reducing blood transfusions in the anemia of prematurity | Q73685494 | ||
| Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo-controlled, multicenter trial | Q73735052 | ||
| Erythropoietin therapy for premature infants: cost without benefit? | Q74112088 | ||
| Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g | Q74390917 | ||
| Single-dose darbepoetin administration to anemic preterm neonates | Q81189218 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | birth mass | Q4128476 |
| erythropoietin | Q218706 | ||
| preterm infant | Q45051448 | ||
| P304 | page(s) | CD004865 | |
| P577 | publication date | 2006-07-19 | |
| P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
| P1476 | title | Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants |
| Q39052915 | Advances in understanding and management of retinopathy of prematurity |
| Q37375095 | Anemia in the preterm infant: erythropoietin versus erythrocyte transfusion--it's not that simple |
| Q40323207 | Characterization and differentiation of iron status in anemic very low birth weight infants using a diagnostic nomogram |
| Q85204911 | Early administration of erythropoietin in the extreme premature, a risk factor for retinopathy of prematurity? |
| Q47176323 | Early erythropoiesis-stimulating agents in preterm or low birth weight infants |
| Q89672648 | Early erythropoiesis-stimulating agents in preterm or low birth weight infants |
| Q24195000 | Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants |
| Q24197981 | Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants |
| Q89672645 | Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants |
| Q36059793 | Epo and other hematopoietic factors |
| Q37678885 | Erythropoietin for infants with hypoxic-ischemic encephalopathy |
| Q47211232 | Late-onset neutropenia: defining limits of neutrophil count in very low birth weight infants |
| Q55715494 | Les transfusions de culot globulaire aux nouveau-nés. |
| Q24235360 | Low versus high haemoglobin concentration threshold for blood transfusion for preventing morbidity and mortality in very low birth weight infants |
| Q33390642 | Neonatal thrombocytopenia and megakaryocytopoiesis |
| Q34735110 | New-onset maternal gestational hypertension and risk of retinopathy of prematurity |
| Q35225120 | Possibility of enhanced risk of retinal neovascularization in repeated blood donors: blood donation and retinal alteration |
| Q36409513 | Protective effects of Cynara scolymus leaves extract on metabolic disorders and oxidative stress in alloxan-diabetic rats |
| Q38214086 | Red blood cell transfusion in newborn infants |
| Q34508617 | Respective effects of phlebotomy losses and erythropoietin treatment on the need for blood transfusion in very premature infants |
| Q35201430 | The biological basis of injury and neuroprotection in the fetal and neonatal brain |
| Q38110390 | The biology of retinopathy of prematurity: how knowledge of pathogenesis guides treatment |
| Q89879457 | Treatment of Neonatal Hypoxic-Ischemic Encephalopathy with Erythropoietin Alone, and Erythropoietin Combined with Hypothermia: History, Current Status, and Future Research |
Search more.